The effect of pergolide mesylate on adrenocorticotrophic hormone responses to exogenous thyrotropin releasing hormone in horses

Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia dysfunction

(2021) Natalie Hague et al.   VETERINARY RECORD

The accuracy of ACTH as a biomarker for Pituitary Pars Intermedia Dysfunction in horses: A systematic review and meta‐analysis

(2021) James C. Meyer et al.   EQUINE VETERINARY JOURNAL

Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic review

(2021) R.C. Tatum et al.   VETERINARY JOURNAL

Repeatability of a thyrotropin‐releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses

(2021) Yan Ning Kam et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse

(2020) Andy E. Durham et al.   EQUINE VETERINARY JOURNAL

Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses

(2020) A.B. Miller et al.   DOMESTIC ANIMAL ENDOCRINOLOGY

Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review

(2020) R.C. Tatum et al.   VETERINARY JOURNAL

Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses

(2020) Remona Horn et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia

(2018) D.P. Byrne et al.   VETERINARY JOURNAL

Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction

(2016) D. McFarlane et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses

(2014) E. Diez de Castro et al.   DOMESTIC ANIMAL ENDOCRINOLOGY

Pituitarypars intermediadysfunction: Diagnosis and treatment

(2014) A. E. Durham et al.   EQUINE VETERINARY EDUCATION

Comparison of Insulin and Glucose Metabolism in Horses with Pituitary Pars Intermedia Dysfunction Treated Versus Not Treated with Pergolide

(2013) Heidrun Gehlen et al.   JOURNAL OF EQUINE VETERINARY SCIENCE

Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitarypars intermediadysfunction

(2011) V. E. N. COPAS et al.   EQUINE VETERINARY JOURNAL

α-Melanocyte—stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction

(2011) Jill Beech et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Comparison of Cortisol and ACTH Responses after Administration of Thyrotropin Releasing Hormone in Normal Horses and Those with Pituitary Pars Intermedia Dysfunction

(2011) J. Beech et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Seasonal Changes in Plasma Adrenocorticotropic Hormone and α-Melanocyte-Stimulating Hormone in Response to Thyrotropin-Releasing Hormone in Normal, Aged Horses

(2011) R.A. Funk et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide

(2007) G. A. PERKINS et al.   EQUINE VETERINARY JOURNAL